Longevity & AgingForschungsarbeitOpen Access

Irregular sleep timing drives lower wellbeing in cirrhosis, ring-tracking study finds

Six months of Oura Ring data from 88 cirrhosis patients show sleep regularity mediates about half of the link between liver disease severity and quality of life.

Montag, 16. November 2026 1 Aufruf
Veröffentlicht in JHEP Rep
Close-up of a hand wearing a smart ring on a nightstand beside a clock at 3 AM, dim bedroom, soft blue glow, rumpled sheets.

Zusammenfassung

Poor wellbeing is common in cirrhosis, and sleep is a major contributor, but it is rarely measured in clinics. Researchers gave 119 patients with cirrhosis an Oura Ring and followed them for up to 6 months, analyzing 12,516 sleep episodes from 88 participants. They compared wearable sleep metrics with the Chronic Liver Disease Questionnaire (CLDQ) and the Pittsburgh Sleep Quality Index (PSQI). Patients with worse quality of life slept less efficiently and later, but the Sleep Regularity Index (SRI), which measures consistency of sleep-wake timing across days, stood out. SRI was lower in more advanced disease and in patients with cognitive impairment. It mediated 49.9% of the relationship between Child-Turcotte-Pugh score and CLDQ. Sleep regularity may be a practical digital biomarker and a target for circadian-focused interventions, though causality is unproven.

Detaillierte Zusammenfassung

Cirrhosis impairs health-related quality of life (HRQoL) even before major complications appear, and HRQoL independently predicts hospitalization and death. Lab-based severity scores such as MELD explain only part of this burden. Sleep disturbance is highly prevalent in liver disease, but clinical sleep assessment is cumbersome, and it is unclear which aspects of sleep matter most. Sleep irregularity, a hallmark of circadian disruption, had not been formally quantified over long periods in this population.

The researchers enrolled 119 ambulatory patients with cirrhosis at Weill Cornell and Columbia between 2023 and 2025. Participants wore an Oura 3.0 ring day and night for up to 6 months and completed baseline cognitive testing (including PHES), the CLDQ, and the PSQI. The analytic cohort comprised 88 participants with at least 14 valid days, contributing 12,516 sleep episodes of at least 1 hour. The primary outcome was the Sleep Regularity Index (SRI) and its association with CLDQ. Analyses used mixed-effects models with participant-level random intercepts, ordinal tertile models, and causal mediation analysis (2,000 bootstrap simulations, adjusted for age and sex).

Mean age was 55, 45.5% were female, and 79.5% reported poor sleep (PSQI ≥5). Poor sleepers had lower SRI (81.6 vs 84.3, p=0.015), less sleep, later sleep onset and midpoint, and more variable timing. Patients with impaired HRQoL (CLDQ <5) had lower SRI (81.1 vs 83.3), lower sleep efficiency (77.8% vs 81.9%) driven by more wake after sleep onset (90.7 vs 69.7 min), and similar total sleep duration. CLDQ and PSQI were strongly inversely correlated (r = -0.61). Lower SRI was associated with higher CTP score, higher MELD 3.0, prior decompensation, and worse cognition (PHES, Stroop, animal naming). Patients in higher SRI tertiles had much higher odds of good sleep quality (OR 6.19) and better CLDQ (OR 4.44). In mediation analysis, SRI was the strongest mediator of the CTP-to-CLDQ relationship (ACME -0.093, p<0.001; 49.9% mediated). Among patients with CTP ≥7, lower SRI and sleep efficiency still tracked with worse sleep quality.

The findings suggest sleep regularity could serve as a scalable, passively collected digital biomarker of impaired wellbeing and disease progression in cirrhosis, and a candidate target for circadian-directed interventions such as consistent sleep-wake scheduling, light exposure, or timed behavioral therapy. Wearables may make longitudinal sleep assessment feasible in routine care.

Important caveats apply. The design is observational, so the mediation estimates do not prove causality, and reverse causation is plausible, since poor wellbeing or encephalopathy may itself disrupt sleep regularity. Sleep staging came from a proprietary consumer algorithm that was not validated against polysomnography in this cohort. The sample was modest, the effect sizes small in absolute terms (a few SRI points), and about 21% of possible days were lost to non-adherence. The cohort was ambulatory, relatively compensated, and mostly non-drinking, which limits generalizability. No intervention was tested.

Wichtigste Erkenntnisse

  • Wearable sleep tracking of 88 cirrhosis patients yielded 12,516 sleep episodes over up to 6 months.
  • Sleep Regularity Index mediated 49.9% of the effect of Child-Turcotte-Pugh score on quality of life (ACME -0.093, p<0.001).
  • Higher SRI tertile carried 6.19-fold odds of good sleep quality and 4.44-fold odds of better CLDQ.
  • Lower SRI was associated with higher CTP and MELD scores, prior decompensation, and worse cognitive test performance.
  • Impaired-wellbeing patients had more nighttime wakefulness (90.7 vs 69.7 min) and later sleep timing despite similar total sleep duration.

Methodik

Prospective two-center observational cohort of 119 ambulatory cirrhosis patients (88 analyzed) wearing an Oura 3.0 ring for up to 6 months, with baseline PSQI, CLDQ, and cognitive testing. Analyses used mixed-effects models, SRI tertile ordinal models, and bootstrapped causal mediation (CTP → sleep metric → CLDQ) adjusted for age and sex.

Studienlimitierungen

The observational design precludes causal inference, and reverse causation or unmeasured confounding (depression, medications, encephalopathy) may explain the mediation findings. The sample was modest and largely compensated or ambulatory, about 21% of days were lost to non-adherence, and the proprietary Oura algorithm was not validated against polysomnography in this population. Absolute SRI differences were small, and many associations were univariable or marginal after adjustment.

Hat dir diese Zusammenfassung gefallen?

Erhalte die neueste Longevity-Forschung jede Woche in deinen Posteingang.

E-Mail-Adresse zum Abonnieren eingeben: